FS Chiron Capital Allocation C CCPCX Fund Analysis

| Medalist Rating as of | See Chiron Capital Investment Hub

Morningstar’s Analysis CCPCX

Will CCPCX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

FS Chiron Capital Allocation C earns a Morningstar Medalist Rating of Negative with strength in areas such as People offset by weaker spots such as Process.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the most expensive quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Sponsor Center